Blues Man
Diamond Member
- Aug 28, 2016
- 35,513
- 14,915
- 1,530
That's all a corporate interest "needs", yeah. We did those experiments, review the legacy.All you need is a trial group and a control.Because it may have the reverse affect. That's why you have clinical trials.Preliminary data. Calm the markets, figure it out for real later.
Preliminary but promising.
Why not ramp up the testing to a large scale right away?
You're dealing with folks who have no idea what a clinical trial is or what a double blind study is. Don put is own ignorance on very public display relative to this mindset, ... as well as the history that led us to these protocols and procedures.
We are only looking for one metric here and that is the reduction of the viral load.
One small study has already shown that this drug reduces the viral load
Sent from my SM-N960U using Tapatalk
There was an actual trial done in France. It was a small scale study that used a negative control group
French researcher posts successful Covid-19 drug trial